Dld Asset Management, LP Spring Works Therapeutics, Inc. Put Options Transaction History

Dld Asset Management, LP

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 13, 2022	SELL	$48.97 - $65.46 $1.89 Million - $2.52 Million	-38,500 Closed	0 $0
Q4 2021 Feb 22, 2022	SELL	$53.3 - $75.84 $203 Million - $289 Million	-3,811,500 Reduced 99.0%	38,500 $2.39 Million
Q4 2021 Feb 14, 2022	BUY	$53.3 - $75.84 $205 Million - $292 Million	3,850,000 New	3,850,000 $2.39 Million

237

68.9M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.25B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.